Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons
-
Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset
-
Actelis Networks Receives New Order to Support Rail Infrastructure Modernization in Northern Ireland
-
Alarum to Release First Quarter 2025 Results on May 29, 2025
-
Intent IQ Achieves SOC 2 Compliance, Reinforcing Enterprise-Grade Trust in Data Security and Privacy
-
ALX Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Deckhouse Communications and iO3 Collaborate to Bring Advanced Digital Solutions to Turkish Maritime Sector
-
Giftify's CardCash.com Leverages NBA Playoff Enthusiasm to Accelerate Platform Growth
-
Siebert Financial Appoints Industry Veteran Fredrick Scuteri as Chief Operating Officer of its Broker-Dealer Subsidiary
-
Fluent, Inc. and Rebuy Partner to Unlock Post-Purchase Advertising for Shopify Merchants
-
Consumer Portfolio Services Deploys AI-Powered Servicing Platform from Salient to Advance Collections Strategy
-
FST Corp. Reports Significant Spike in Sales Following Tournament Wins in 2024
-
HepaRegeniX Scientific Founder Covers HRX-215 Development and Clincial Data in Plenary at the European Association for the Study of the Liver Congress 2025
-
MEXC Lists Doodles (DOOD) with 50,000 USDT Worth of DOOD and 50,000 USDT Bonus Prize Pool
-
PeakMetrics Appoints Noha Georges to Its Board of Advisors
-
STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference
-
CERo Therapeutics Holdings, Inc. Regains Compliance with Nasdaq Listing Rule 5550(b)(1)
-
CERo Therapeutics Holdings, Inc. Regains Compliance with Nasdaq Listing Rule 5550(b)(1)
-
ZenaTech’s ZenaDrone Tests Proprietary Camera Enabling IQ Nano Drone Swarms for US Defense Applications and Blue UAS Submission
-
Yamo Pharma Presents Statistically Significant Phase 2 Autism Results for L1-79 at INSAR 2025
-
21Shares AG - Publication of Base Prospectus
-
The Joint Commission and Palantir Technologies Announce Strategic Partnership to Elevate Patient Safety and Healthcare Standards
-
NKGen Biotech Chairman & CEO Paul Y. Song, M.D., Personally Invests $2.65 Million Cash to Accelerate Phase 2 Clinical Trial and Fulfill Financial Reporting Obligations
-
Beyond Green Welcomes Six New Member Properties
-
MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update
-
IMUNON Announces First Site Initiated for Pivotal Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer
-
StepStone Group to Announce Fourth Quarter and Fiscal 2025 Results on May 22, 2025
-
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
-
Xometry to Participate in Upcoming Investor Conferences
-
HENRY CATCHPOLE TAKES TO THE TRACK IN RARE HONDA NSX-R IN SWEDEN AHEAD OF BROAD ARROW'S FIRST EUROPEAN AUCTION
-
Parex Resources Announces First Quarter Results, Declaration of Q2 2025 Dividend, and Operational Update
-
Zscaler to Host Third Quarter Fiscal Year 2025 Earnings Conference Call
-
Alzamend Neuro Announces Reverse Stock Split
-
REMINDER: Lassonde Industries Inc. Will Hold a Conference Call to Discuss Its First Quarter 2025 Financial Results
-
Studio City International Holdings Limited Announces Unaudited First Quarter 2025 Earnings
-
Melco Announces Unaudited First Quarter 2025 Earnings
-
HENRY CATCHPOLE TAKES TO THE TRACK IN RARE HONDA NSX-R IN SWEDEN AHEAD OF BROAD ARROW'S FIRST EUROPEAN AUCTION
-
The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates
-
Core Molding Technologies Reports Fiscal 2025 First Quarter Results
-
Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update
-
ORYZON Awarded €13.26 Million Through the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)
-
Enphase Energy Announces Easy Expansion of IQ7 Solar Systems with IQ8 Microinverters
-
Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference
-
xSuite Group Partners with Trenex Consulting to Expand Global Reach
-
Aemetis Reports First Quarter 2025 Financial Results
-
Infinidat Wins 2025 Global InfoSec Awards for Cyber Resilience, Cyber Storage, and Ransomware Recovery from Cyber Defense Magazine
-
Perma-Fix Reports Q1 2025 Results and Highlights Momentum in Hanford and PFAS Programs
-
Cue Biopharma to Host Virtual Investor Event on May 15, 2025
-
Capital Clean Energy Carriers Corp. Announces First Quarter 2025 Financial Results and Employment for Two LNG Carriers ("LNG/C") Under Construction
-
Scality named a 2025 Stevie Award winner
